评估糖尿病特异性餐饮替代品,以控制T2DM超重和肥胖患者的血糖水平:一种随机对照试验的协议
Wan Ain Nadirah Che Wan Mansor1, Suzana Shahar1, Noorlaili Mohd Tohit2
1Centre for Healthy Ageing and Wellness, Faculty of Health Sciences, Universiti Kebangsaan Malaysia, Kuala Lumpur, Malaysia.
BMJ open
|October 10, 2025
概括
这项研究研究了2型糖尿病的替代性饮食疗法,显示了其在肥胖患者中减肥和改善血糖控制的潜力. 进一步的分析包括代谢健康和成本效益.
科学领域:
- 内分泌学 在内分泌学.
- 代谢综合征是代谢综合征的一种.
- 营养科学 营养科学
背景情况:
- 无法控制的2型糖尿病 (T2DM) 呈现出显著的微血管和宏血管并发症,全球增加了医疗保健负担.
- 以前对T2DM的替代性饮食 (MR) 治疗的研究已经产生了不一致的结果,需要进一步调查.
- 患有T2DM的超重和肥胖个体特别容易受到疾病进展和相关并发症的影响.
研究的目的:
- 评估糖尿病特异性MR产品在控制体重和改善T2DM超重和肥胖患者的血糖控制方面的疗效.
- 评估MR治疗对腹感,生活质量,代谢基因表达和成本效益的影响.
- 提供来自随机对照试验的可靠数据,以告知临床实践和患者的结果.
主要方法:
- 一项随机对照试验涉及164名超重/肥胖T2DM参与者,他们被分配到干预组 (MR+饮食咨询) 或对照组 (仅饮食咨询) 12周.
- 主要结局包括血糖控制和肥胖指标的变化;次要结局包括心血管风险标志物,代谢概况,基因表达,腹感,生活质量和成本效益.
- 数据收集包括基线和6/12周的随访,包括人体测量,血压,代谢标记,基因表达和患者报告的结果,并使用SPSS V.29.0 (p<0.05) 进行统计分析.
主要成果:
- (由于研究仍在进行中,结果尚未提供)
结论:
- (在研究完成和数据分析后得出的结论)
相关概念视频
Insulin: Dosing Regimen and Adverse Effects
680
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
680
Diabetes Mellitus: Type 2 and Gestational
4.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.3K
Diabetes: Management and Pharmacotherapy
867
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
867
Carbohydrate Metabolism
13.8K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
13.8K
Oral Hypoglycemic Agents: Biguanides and Glitazones
583
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
583
Diabetes Mellitus: Overview and Type I Subtype
4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K


